Giardia lamblia is one of the most important worldwide causes of intestinal infections produced by protozoa. Current therapy for giardiasis is unsatisfactory due to high incidence of undesirable side effects and significant failure in clearing parasites from the gastrointestinal tract. In the search for new therapeutic agents, we report on the effect of several essential oils on G. lamblia growth. Among eighteen tested essential oils, those with phenolic compositions were the most active, particularly if containing high contents of carvacrol, such as Thymbra capitata and Origanum virens (IC 50 values of 71 and 85 µg.mL -1 , respectively). The oils from Syzygium aromaticum and Thymus zygis subsp. sylvestris (IC 50 values from 100 to 200 μg.mL -1 ), as well as, those from Mentha x piperita and Lippia graveolens (IC 50 values over 200 μg.mL -1 ) were less active. Results support the concept that several essential oils or some of their constituents may be useful in the clinical management of Giardia infections.
Giardia lamblia is a binucleated, flagellar protozoan that commonly causes intestinal infection in humans, being a factor of extensive morbidity worldwide [1] . This pathogen has two different stages during its life cycle: the cystic form that is responsible for the transmission of disease and the trophozoitic form, which inhabits the host's small intestine. In order to establish the parasitism, trophozoites adhere to the intestinal cells leading to malnutrition syndrome, diarrhea, nausea, cramps and weight loss [2, 3] . Giardiasis may be entirely asymptomatic or may produce a mild self-limiting illness. In the young, elderly, and immunocompromised patients, giardiasis can lead to morbidity and even death [4] . Giardiasis is especially prevalent in developing countries, where inefficient sanitary conditions facilitate its propagation. In developed nations a rising incidence of giardiasis has led to its classification as a "re-emerging" infectious disease [1] . Several drugs have been developed in the last years in order to treat this illness, including 5-nitroimidazoles, 5-nitrofurans and, more recently, benzimidazoles and pyrantel pamoate, which are the drugs of choice. Although these drugs are effective, many problems have been described associated with their use ranging from unpleasant side effects and treatment failures to concerns about carcinogenicity, teratogenicity and embryogenicity [5] . Furthermore, some studies showed an increasing tolerance of clinical isolates of G. lamblia to the above-listed drugs [6] . For these reasons, the search for therapeutic alternatives is justifiable and imperative. Screening plant extracts, as well as synthetic compounds, for anti-Giardia activity is a valuable research option. Plant extracts offer a huge diversity of compositions and constituents, most of them commercially unavailable and structurally difficult to synthesize. Several plant extracts have already been tested for anti-Giardia activity [7] [8] [9] [10] [11] [12] [13] [14] , but most of them were aqueous or alcoholic extracts, and so were exclusively composed of polar molecules. However, other kinds of extract could offer advantages and new expectations. Extracts prepared by distillation are complex mixtures of small (<300 Da) hydrophobic molecules, most of which satisfy the criteria for the theoretical approach to predict drug likeness [15] . Such molecules easily diffuse across cell membranes and are able to interact with intracellular targets [16] . The potential use of essential oils as natural antimicrobial agents against yeasts, filamentous fungi and bacteria has already been demonstrated by our group [17] [18] [19] [20] [21] [22] [23] [24] . De Almeida et al [25] and Moon et al. [26] reported the effects of the essential oils from Ocimum basilicum L., Lavandula angustifolia and L. × intermedia on Giardia species. In the present work, we focused on the screening of other essential oils for anti-Giardia activity. A set of eighteen essential oils was chosen, based on their chemical diversity.
Chemical diversity and compositional data of the eighteen tested essential oils are summarized in Table 1 .
Compositions were extensively characterized attaining identification rates of over 90%, except for Eryngium maritimum oil, for which only 71.8% of the composition was elucidated. In general, these results are analogous to the typical compositions of the oils from each source species and type. In this set of essential oils, more than one hundred different compounds were identified, being representative of the major chemical families reported for this type of essential oil. Fortyseven compounds were found in concentrations over 2.0% in, at least, one essential oil. Six monoterpene hydrocarbons, α-pinene, β-pinene, myrcene, limonene, p-cymene, and γ-terpinene, eleven oxygen-containing monoterpenes, 1,8-cineole, camphor, borneol, menthofuran, isomenthone, pulegone, menthol, thymol, carvacrol, geraniol and geranyl acetate, the sesquiterpene germacrene D and the phenylpropanoids eugenol and dillapiole exceeded 10.0% of the total composition of, at least, one essential oil. These in-vitro results showed that some essential oils can be inhibitors of G. lamblia growth and thus be hopeful sources of active or lead molecules. Taking into account that essential oils are complex mixtures of compounds present in a wide range of concentrations, IC 50 values under 200 µg/mL are indicators of the promising effectiveness of the oils or some of their constituents as anti-giardiasis agents. Whatever the constituent or constituents responsible for the activity of the oils, its (their) computed IC 50 mMolar values can be comparable with that of metronidazole (IC 50 = 0.26 mM) [27] , the "gold standard" and the most often used drug for the treatment of giardiasis.
Looking for a relationship between the composition of the oils and their activity profiles, giardicidal potential could be associated with phenolic compositions, particularly those of oils with high carvacrol contents, such as T. capitata (74.6%) and O. virens (68.2%). The results justify further investigations in order to validate and improve the use of these essential oils, or some of their purified constituents, as therapeutic alternatives for giardiasis. Components of each essential oil were identified by RIs on both SPB-1 and SupelcoWax-10 columns and from their MS. RIs, calculated by linear interpolation relative to retention times of C 8 -C 23 n-alkanes, were compared with those of authentic samples included in our own laboratory database. Acquired MS were compared with reference spectra from our own database, Wiley / NIST database [29] and literature data [30, 31] . Relative amounts of individual components were calculated based on GC raw data without further correction. [32] . Penicillin G (250 mg/mL) and streptomycin sulfate (250 mg/mL) were added during routine culture. Log-phase cultures (2-3 days) were harvested by cooling culture vials (4ºC/15 minutes) and centrifugation (1500 g for 5 min). Trophozoites were washed 3 times and then counted in a Neubauer cellcounter chamber. These cells were used to study the effects of essential oils on G. lamblia trophozoites growth.
Experimental
Growth inhibition assays: Susceptibility of G. lamblia growth to essential oils in vitro was determined as previously described [27, 33] . Essential oils were diluted in dimethylsulfoxide (DMSO; Sigma Chemical) at 100 mg/mL and then in TYI-S-33 medium in order to get a range of concentrations from 10 to 400 μg/mL. G. lamblia cells (5 x 10 4 ), in fresh culture medium containing the added essential oil solutions, were incubated in 1.5 mL Eppendorff vials at 37ºC for 48 h. Control tests were performed under the same conditions, but by replacing the essential oil solutions with dimethylsulfoxide at the highest concentration used in the tests. Another set of controls was performed by incubating cells in culture medium without any addition. After incubation, the vials were cooled at 4ºC and the detached trophozoites were counted under a light microscope (Nikon Eclipse E100). Cell number results, expressed as percentage of the total cells in the control, were used to determine the concentration of essential oil that inhibits 50% of the cells (IC 50 ).
All experiments were performed in duplicate in at least 3 independent assays. The mean and the standard error of the mean (SEM) of the experiments were determined. IC 50 values were estimated by interpolation from dose-response regressions plotted by GraphPad Prism 5.
